Humana Inc. (NYSE:HUM) Shares Sold by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System lowered its position in shares of Humana Inc. (NYSE:HUM) by 6.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 6,437 shares of the insurance provider’s stock after selling 435 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Humana were worth $1,633,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Xponance Inc. lifted its position in Humana by 0.8% during the 4th quarter. Xponance Inc. now owns 17,649 shares of the insurance provider’s stock worth $4,478,000 after acquiring an additional 137 shares during the period. Boston Partners lifted its position in Humana by 435.8% during the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock worth $279,236,000 after acquiring an additional 893,637 shares during the period. Generali Asset Management SPA SGR acquired a new stake in Humana during the 4th quarter worth about $1,948,000. Kennondale Capital Management LLC acquired a new position in shares of Humana in the 4th quarter valued at about $7,056,000. Finally, Retirement Planning Co of New England Inc. lifted its holdings in shares of Humana by 4.7% in the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after buying an additional 43 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

NYSE:HUM opened at $266.33 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The stock has a 50 day moving average of $271.33 and a two-hundred day moving average of $277.52. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $32.14 billion, a P/E ratio of 26.77, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several analyst reports. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Truist Financial boosted their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Barclays boosted their price objective on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Finally, Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $285.68.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.37% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.